Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wonshik Han

Showing results (371-380 of 384) with videos related to

Pageof 39
Sort By:
Future Oncology (London, England)|May 9, 2015
Personalization of loco-regional care for primary breast cancer patients (part 1)Masakazu Toi, Eric P Winer, John R Benson, et al.
Future Oncology (London, England)|May 9, 2015
Personalization of loco-regional care for primary breast cancer patients (part 2)Masakazu Toi, Eric P Winer, John R Benson, et al.
Nature Communications|May 9, 2022
Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell micronichesAmos C Lee, Yongju Lee, Ahyoun Choi, et al.
Endocrine-Related Cancer|September 1, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancerTakayuki Ueno, Louis W C Chow, Wonshik Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2019
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III TrialHyun-Ah Kim, Jong Won Lee, Seok Jin Nam, et al.
BMC Cancer|March 12, 2014
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)Jisun Kim, Woosung Lim, Eun-Kyu Kim, et al.
Familial Cancer|November 8, 2012
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer studySang-Ah Han, Sung-Won Kim, Eunyoung Kang, et al.
Journal of Breast Cancer|April 5, 2021
Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)Sung Gwe Ahn, Seok Jin Nam, Sei Hyun Ahn, et al.
Psycho-Oncology|April 21, 2020
Efficacy of health coaching and a web-based program on physical activity, weight, and distress management among cancer survivors: A multi-centered randomised controlled trialYoung Ho Yun, Cheol Il Lim, Eun Sook Lee, et al.
BMC Cancer|May 21, 2016
The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progressHyun-Ah Kim, Sei Hyun Ahn, Seok Jin Nam, et al.
Pageof 39

Showing results (371-380 of 384) with videos related to

Sort By:
Pageof 39
Future Oncology (London, England)|May 9, 2015
Personalization of loco-regional care for primary breast cancer patients (part 1)Masakazu Toi, Eric P Winer, John R Benson, et al.
Future Oncology (London, England)|May 9, 2015
Personalization of loco-regional care for primary breast cancer patients (part 2)Masakazu Toi, Eric P Winer, John R Benson, et al.
Nature Communications|May 9, 2022
Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell micronichesAmos C Lee, Yongju Lee, Ahyoun Choi, et al.
Endocrine-Related Cancer|September 1, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancerTakayuki Ueno, Louis W C Chow, Wonshik Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2019
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III TrialHyun-Ah Kim, Jong Won Lee, Seok Jin Nam, et al.
BMC Cancer|March 12, 2014
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)Jisun Kim, Woosung Lim, Eun-Kyu Kim, et al.
Familial Cancer|November 8, 2012
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer studySang-Ah Han, Sung-Won Kim, Eunyoung Kang, et al.
Journal of Breast Cancer|April 5, 2021
Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)Sung Gwe Ahn, Seok Jin Nam, Sei Hyun Ahn, et al.
Psycho-Oncology|April 21, 2020
Efficacy of health coaching and a web-based program on physical activity, weight, and distress management among cancer survivors: A multi-centered randomised controlled trialYoung Ho Yun, Cheol Il Lim, Eun Sook Lee, et al.
BMC Cancer|May 21, 2016
The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progressHyun-Ah Kim, Sei Hyun Ahn, Seok Jin Nam, et al.
Pageof 39